Header image

Řezníčková Eva
Journals
Characterization of new highly selective pyrazolo[4,3-d]pyrimidine inhibitor of CDK7.
Biomedicine & Pharmacotherapy.
2023,
161,
114492,
ISSN: 0753-3322,
PMID: 36931035,
Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines.
Investigational New Drugs.
2023,
41(2),
210-219,
ISSN: 0167-6997,
PMID: 36913160,
Synthesis and Structural Optimization of 2,7,9-Trisubstituted purin-8-ones as FLT3-ITD Inhibitors.
International Journal of Molecular Sciences.
2022,
23(24),
16169,
ISSN: 1422-0067,
PMID: 36555810,